A programmed turnover of pancreatic ␤ cells occurs in the neonatal rat involving a loss of ␤ cells by apoptosis, and their replacement by islet cell replication and neogenesis. The timing of apoptosis is associated with a loss of expression of a survival factor, insulin-like growth factor-II (IGF-II), in the pancreatic islets. Offspring from rats chronically fed a low protein isocalorific diet (LP) exhibit a reduced pancreatic ␤ cell mass at birth and a reduced insulin secretion in later life. This study therefore investigated the impact of LP on islet cell ontogeny in the late fetal and neonatal rat, and any associated changes in the presence of IGFs and their binding proteins (IGFBPs). Pregnant Wistar rats were fed either LP (8% protein) or normal (C) (20% protein) chow from shortly after conception until the offspring were 21 days postnatal (PN). Bromo-deoxyuridine (BrdU) was administered 1 h before rats were killed and pancreata removed from animals between 19.5 days fetal life and postnatal day 21. Offspring of rats given LP diet had reduced birthweight, pancreatic ␤ cell mass, and pancreas insulin content, with smaller islets compared with control fed animals, which persisted to weaning. Histological analysis showed that islets from pups given LP diet had a lower nuclear labeling index with BrdU in the ␤ cells, although, paradoxically, more ␤ cells showed immunoreactivity for proliferating cell nuclear antigen (PCNA). Because PCNA is present in G1 as well as S phase of the cell cycle, we quantified the number of ␤ cells immunopositive for cyclin D1, a marker of G1, and NEK2, an indicator of cells in G2 and mitosis. More ␤ cells in islets from LP-fed animals contained cyclin D1, but less contained NEK2 than did those in controls. This suggests that the ␤ cell cycle may have a prolonged G1 phase in LP-fed animals in vivo. Offspring of rats given C diet had a low rate of islet cell apoptosis detected by the TUNEL method in fetal and neonatal life (1-2%), with a transient increase to 8% at PN day 14. Offspring of rats receiving LP diet demonstrated a significantly greater level of islet cell apoptosis at every age, rising to 15% at PN 14. IGF-II mRNA was quantified in whole pancreas and was significantly reduced in LP-fed animals at ages up to PN day 10. IGF-II immunoreactivity within the islets of LP-fed rats was also less apparent, but no changes were seen in immunoreactive IGF-I or IGFBPs-2 to -5. These findings show that LP diet changes the balance of ␤ cell replication and apoptosis in fetal and neonatal neonatal life, which may involve an altered length of ␤ cell cycle, and contribute to the smaller islet size and impaired insulin release seen in later life. A reduced pancreatic expression of IGF-II may contribute to the lower ␤ cell proliferation rate and increased apoptosis seen in the fetus and neonate after feeding LP diet. (Endocrinology 140: [4861][4862][4863][4864][4865][4866][4867][4868][4869][4870][4871][4872][4873] 1999) 
cause PCNA is present in G1 as well as S phase of the cell cycle, we quantified the number of ␤ cells immunopositive for cyclin D1, a marker of G1, and NEK2, an indicator of cells in G2 and mitosis. More ␤ cells in islets from LP-fed animals contained cyclin D1, but less contained NEK2 than did those in controls. This suggests that the ␤ cell cycle may have a prolonged G1 phase in LP-fed animals in vivo. Offspring of rats given C diet had a low rate of islet cell apoptosis detected by the TUNEL method in fetal and neonatal life (1-2%), with a transient increase to 8% at PN day 14. Offspring of rats receiving LP diet demonstrated a significantly greater level of islet cell apoptosis at every age, rising to 15% at PN 14. IGF-II mRNA was quantified in whole pancreas and was significantly reduced in LP-fed animals at ages up to PN day 10. IGF-II immunoreactivity within the islets of LP-fed rats was also less apparent, but no changes were seen in immunoreactive IGF-I or IGFBPs-2 to -5. These findings show that LP diet changes the balance of ␤ cell replication and apoptosis in fetal and neonatal neonatal life, which may involve an altered length of ␤ cell cycle, and contribute to the smaller islet size and impaired insulin release seen in later life. A reduced pancreatic expression of IGF-II may contribute to the lower ␤ cell proliferation rate and increased apoptosis seen in the fetus and neonate after feeding LP diet. (Endocrinology 140: [4861] [4862] [4863] [4864] [4865] [4866] [4867] [4868] [4869] [4870] [4871] [4872] [4873] 1999) F ETAL UNDERNUTRITION can result in intrauterine growth restriction (IUGR), reduced birthweight, and an increased incidence of adult onset diseases such as type 2 diabetes and coronary heart disease (1-3). We have used a model in which pregnant rats receive throughout gestation a low protein (LP). Birthweight is significantly reduced in the offspring of LP rats that have altered blood amino acid profiles, although blood glucose and plasma insulin levels do not differ greatly from controls (4) . The pancreatic weight is significantly lower in LP pups at birth as is mean islet area (5), due in part to a reduced proliferative capacity and also, perhaps, to a reduced vascularity in the endocrine pancreas (5) . These animals have also been studied at adult age following a lactation by mothers receiving normal protein intake and fed a normal diet after weaning. As adults, they feature a slight reduction in the islet cell mass and a low pancreatic insulin content. An abnormally low release of insulin in response to amino acids was found when isolated islets were examined in vitro, and lower insulin response to a oral glucose challenge in vivo was observed in females (6 -8) . Clearly, dietary experiences in utero can lead to long-lasting functional deficiencies in the endocrine pancreas and can program a susceptibility to abnormal glucose tolerance.
Potentially important events in pancreatic islet ontogeny have been recognized in the neonatal rat, which may explain why this is a period of sensitivity to nutritional insult. In the rat fetus islet cell, mass increases rapidly due to both ␤ cell replication and recruitment, and maturation of undifferentiated ␤ cell precursors within the pancreatic ducts (9, 10) . Following birth, the growth rate of all islet cells, including ␤ cells, declines within 3-4 days and continues to decline thereafter (10) , so that the rate of mitosis in adult pancreatic ␤ cells is low (11) . A wave of apoptosis occurs in neonatal rat islets between 1-2 weeks of age (12) , although because the total pancreatic ␤ cell mass is not substantially changed this suggests that a new population of ␤ cells derived from replication or neogenesis compensates for the loss. A similar ␤ cell apoptosis has recently been described in the human fetal pancreas in third trimester (13) . This ontogeny of ␤ cells may signal a change from a population suited to fetal life in which acute insulin release is not necessary within a stable nutritional environment, to ␤ cells with altered glucose thresholds and the ability to rapidly release insulin under nutritional, endocrine and neural control characteristic of adult metabolic control.
We recently showed that the timing of neonatal ␤ cell apoptosis in the rat coincided with a loss of expression of insulin-like growth factor-II (IGF-II) within the pancreatic islets, and that IGFs can functionally act as a survival factors to prevent apoptosis in ␤ cells (14) , a role consistent with the actions of IGFs in other cell types (15, 16) . There is also considerable evidence that the IGFs contribute to ␤ cell growth, maturation, and function throughout life, and that their actions can be modulated by locally produced IGF binding proteins (IGFBPs). Messenger RNA for IGF-II is abundant in the pancreas of the fetal rat, and declines rapidly within 2 weeks of birth, whereas IGF-I mRNA expression is low in the fetus, but increases to adult levels by weaning (17) . Isolated islets from the human fetus (18), or rat fetus or neonate (19, 20) , release IGF-I and/or -II, which are capable of increasing islet cell DNA synthesis (19 -21) . The mitogenic action of IGF-II in isolated fetal rat islets was potentiated by IGFBPs-1 and-2, which together with other IGFBPs are expressed there (19) . Both IGF-I and -II can also rapidly modulate insulin release from adult rat islets in a biphasic manner (22, 23) .
The IGF axis is highly responsive to nutritional status (24, 25) . Intrauterine growth restriction in man (26, 27) , and experimentally induced growth retardation in the rat fetus (28 -30) , including protein restriction (31) , is associated with a reduction in circulating IGFs and an altered presence of IGFBPs. Using isolated islets from the fetal rat pancreas or adult hamster, the release of IGFs and IGFBP-1 and -2 were shown to be enhanced by amino acids and/or glucose (19, 32) .
Because of the reorganization of the endocrine pancreas during the suckling period, and the role of amino acids in ␤ cell development, the purpose of this study was to, firstly, examine how LP diet might alter the balance of islet cell replication and survival in the late fetal and neonatal rat endocrine pancreas; and, secondly, to establish if alterations in the pancreatic expression of the IGF axis might be temporally associated with induced developmental changes.
Materials and Methods

Animal model
The model of pre-and postnatal exposure to a low protein diet has been described by us previously (5) . Adult female Wistar rats bred at the Catholic University of Louvain were given food and water ad libitum and were housed at 24 C with a 60% humidity and a 14-h light, 10-h dark cycle. Nulliparous rats of 200 -220 g maintained on standard laboratory diet were time mated and randomly allocated to one of the two groups on day 1 of gestation until weaning. A control group (C) was provided with a 20% protein diet and a second group (LP) was given an 8% protein diet (Hope Farms, Woerden, The Netherlands). The two diets had a similar fat content and were made isocalorific by the addition of carbohydrates to the LP diet. We have previously shown that food intake is not appreciably different between the control and LP groups (5) .
At the time of birth, litters from both diet groups were reduced to eight pups, and these remained with the lactating females until they were killed at up to 21 days. Pregnant rats were anesthetized with pentobarbital (55 mg/kg body weight) on days 19.5 or 21.5 gestation. The abdomen and uterus was opened, and fetal blood samples collected through the axillary vessels; the fetus remaining attached to the mother via the placenta throughout the procedure. Postnatally, pups were killed by decapitation. Because of the higher incidence of glucose intolerance in the adult female offspring of rats subjected to the LP diet during pregnancy (8) , only female offspring was used in this experiment. Pregnant mothers or pups were injected sc with 5-bromo-2-deoxyuridine (BrdU, 50 mg/kg body weight in sterile saline, Roche Molecular Biochemicals Biochemica, Brussels, Belgium) 1 h before sacrifice to label newly formed DNA. At the time of death the animals were weighed and pancreas removed from each animal and either snap-frozen in liquid nitrogen and stored at Ϫ80 C, for RNA isolation, or fixed for immunohistochemistry or in situ hybridization. If pancreata were to be used for histology they were placed in ice-cold fixative (4% paraformaldehyde in 70 mm phosphate buffer, pH 7.4, containing 0.2% glutaraldehyde) for 16 h at 4 C, followed by four washes at 4 C in PBS over a 48-h period. Fixed tissues were dehydrated through a graded ethanol series, impregnated with butanol and embedded in paraffin. All procedures were performed with approval of the animal ethics committees of the Catholic University of Louvain and the University of Western Ontario, and in accordance with the guidelines of the Canadian Council on Animal Care.
Fifty microliters of blood was collected for glucose and precipitated in 500 l HClO 4 (0.33N). Glucose concentrations were measured using a glucose oxidase test kit (Sigma, St. Louis, MO). Plasma was also prepared, and the insulin content measured by RIA (INSIK-5 P2796, Sorin Biomedica, Saluggio, Italy), using rat insulin for the standard curve (Novo Nordisk, Copenhagen, Denmark). Pancreas (15-25 mg) was removed and homogenized in 5 ml acid-ethanol (0.15 m HCl in 75% [vol/vol] ethanol) and extracted overnight at 4 C. The insulin content was determined by RIA and correlated with body weight.
Northern blot analysis
Total RNA was extracted from pancreata as previously described (17) . Before hybridization, the integrity and relative amounts of RNA from each pancreas were assessed by size separation on 10% agarose TAE (Tris HCl-EDTA) gels with ethydium bromide. Pancreata in which ribosomal RNA showed degradation were not used for experiments.
Northern blot hybridization was performed as described previously (17) using between 15 and 20 g of total RNA following separation by size on agarose gels. Hybridization was performed with 2 ϫ 10 6 cpm/ml radiolabeled complementary DNA (cDNA) probe for IGF-I or -II, or 1 ϫ 10 6 cpm/ml for a cDNA encoding 18S ribosomal RNA. Blots were exposed to x-ray film (Kodak XAR-5, Eastman Kodak Co. Inc., Rochester, NY) at Ϫ70 C with intensifying screens for up to 10 days before developing, and were hybridized consecutively with cDNAs for IGF-II followed by 18S ribosomal RNA. Between consecutive hybridizations, the blots were stripped with 0.01 ϫ SSC with 0.5% (wt/vol) SDS at 90 C for 1 h to remove the previous labeled cDNA probe.
Radiolabeling of cDNA probes with ␣( 32 P)-dCTP (ICN Biomedicals, Inc., Irvine, CA) was carried out by random priming using a Pharmacia oligolabelling kit (Pharmacia LKB Biotechnology, Uppsala, Sweden), to specific activities of 1-2 ϫ 10 9 dpm/g. Separation of radiolabelled cDNA from unincorporated ( 32 P)-dCTP was carried out using 
In situ hybridization
We performed in situ hybridization of IGF-I and -II mRNAs using histological paraffin sections of pancreas as described in detail by us previously (14) . Kodak NTB-3 photoemulsion diluted 1:1 with water was applied subsequently to all sections and exposed for up to 14 days at 4 C, then slides were developed in Kodak D19, rinsed in water and fixed in Kodafix. Sections were counter-stained with hematoxylin and eosin. Slides were viewed under dark and lightfield microscopy. As controls for nonspecific hybridization, hybridization was also carried out using sense strand cRNA probes. Where comparisons were made between pancreata from animals of different ages all sections were included in the same hybridization reactions to remove between procedure error.
Antisense riboprobes were prepared from cDNAs for rat (r) IGF-I (a gift of Dr. L. Murphy, University of Manitoba, Canada), and mouse (m) IGF-II (a gift of Dr. G. Bell, Univ. of Chicago). The restriction enzymes (BRL, Burlington, ON) and RNA polymerases (Promega Corp.) used to linearize the plasmids containing these cDNAs and to generate [
35 S]-radiolabelled riboprobes were: antisense rat IGF I, HindIII/T7; sense rat IGF I, PvuII/SP6; antisense mouse IGF-II, HindIII/TSP6; sense mouse IGF-II EcoRI/T7. Radiolabelled cRNA probes were synthesised using linearized riboprobe DNA, ␣-thio [
35 S]-UTP, and SP6, T3 or T7 RNA polymerase as described previously (14) . To improve cRNA probe penetration of tissue sections, limited alkaline hydrolysis was used to reduce transcript size to about 150 bases.
Immunohistochemistry
Histological sections of pancreas (5 m) were cut from paraffin blocks and mounted on glass microscope slides (Superfrost Plus, Fischer Scientific, Nepeon, ON, Canada). Immunohistochemistry was performed to localize IGF-I or -II, IGFBPs, inducible nitric oxide synthase (iNOS), BrdU, proliferating cell nuclear antigen (PCNA), insulin, glucagon, somatostatin, cyclin D1 and NEK2 within islets by a modified avidin-biotin peroxidase method (34) as described by us previously for pancreas (14) . Slides were incubated for 48 h at 4 4]C with either rabbit antihuman IGF-I or IGF-II (1:2000 dilution) (GroPep Pty. Ltd. Ltd., Adelaide, Australia); rabbit antihuman IGFBP-1, -2, -3, -4 and -5 (all at 1:100 dilution), or monoclonal antibody against human IGFBP-6 (1:500 dilution) (Austral Biologicals, San Remon, CA); guinea pig antiinsulin antibody (1:500 dilution) (provided by Dr. T. J. McDonald, University of Western Ontario, London, Ontario, Canada); rabbit antiporcine glucagon (1:100 dilution) (C-terminal specific 04A antiserum kindly provided by Dr. R. Ungar, Dallas, TX); rabbit antirat somatostatin (1:100) (DAKO Corp. Laboratories, Mississauga, Ontario, Canada); mouse anti-iNOS antiserum (1:50 dilution) (Transduction Laboratories, Inc., Lexington, KY); mouse antiproliferating cell nuclear antigen (PCNA) (1:750 dilution) (Sigma, St. Louis, MO); mouse anti-BrdU (labeling kit supplied by Zymed Laboratories, Inc., South San Francisco, CA); rabbit anti-NEK2 (1 g/ml dilution) (Zymed Laboratories, Inc.); and mouse anticyclin D1 (1:500 dilution) (Zymed Laboratories, Inc.). All antisera were diluted in 0.01 m PBS (pH 7.5) containing 2% (wt/vol) BSA and 0.01% (wt/vol) sodium azide (100 l per slide). Biotinylated goat antirabbit IgG (1:100), goat antimouse IgG (1:100), or mouse antiguinea pig IgG (1:500) (Vector Laboratories, Inc. Burlingame, CA), were used as secondary antibodies. Peptide immunoreactivity was localised by incubation in fresh diaminobenzidine tetrahydrochloride (DAB tablets, 10 mg, Sigma) with 0.03% (vol/vol) hydrogen peroxide for 2 min and the reaction quenched in excess 50 mm Tris.HCl pH 7.5. Tissue sections were counter-stained with Carazzi's hematoxylin.
To establish specificity of staining, the primary antisera for IGF-I or -II were preadsorbed overnight at 4 C with 100 nm homologous antigen before application to the sections. In each case staining was abolished. Antisera against IGFBPs were preabsorbed with 100 nm of homologous or heterologous IGFBP proteins (Austral). All antisera were found to be specific as stated by the supplier with the exception of antiserum against IGFBP-4, which showed cross-reactivity with IGFBP-2. Further controls included substitution of primary antisera with nonimmune serum and omission of the secondary antiserum.
Dual staining for BrdU, PCNA, cyclin D1, or NEK2, and insulin was performed by first performing immunohistochemistry for insulin as described above using diaminobenzidine as the chromagen. Before counterstaining and dehydration the sections were then subjected to immunohistochemistry for the second antigen as described with the exception that alkaline phosphatase (blue) was used as the chromogen. Alkaline phosphatase substrate kit III was obtained from Vector Laboratories, Inc. Antimouse alkaline phosphatase conjugate (Sigma) was applied to each section for 1 h at room temperature, sections washed, and alkaline phosphatase substrate applied for 20 min. Sections were washed and counterstained with Mayer's haemalum.
Visualization of apoptosis
Immunohistochemistry was performed to localize apoptotic nuclei within histological sections of pancreas (35) using the Apoptag in situ apoptosis detection kit (Oncor Inc., Gaithersburg, MD), as described in detail by us previously (14) . Staining was performed according to the manufacturer's protocol, following incubation with proteinase K (20 g/ml; Roche Molecular Biochemicals, Dorval, Québec, Canada) for 15 min, washing in distilled water, and the quenching of endogenous peroxidase by incubation in 2% (vol/vol) hydrogen peroxide in PBS for 5 min. Color was generated with diaminobenzidine as described for immunohistochemistry, and the tissue counterstained with Carazzi's hematoxylin for 1 min. Sections were dehydrated in butanol, cleared in xylene and mounted with Permount under glass coverslips. Duel staining for apoptosis and insulin was performed as described above.
Morphometric and statistical analysis
Morphometric analysis was performed using a Carl Zeiss transmitted light microscope at a magnification of ϫ250 or ϫ400. Analyses were performed with Northern Eclipse version 2.0 morphometric analysis software (Empix Imaging Co., Mississauga, Ontario, Canada). The percentage of islet cells, or the islet cell area, immunopositive for IGF-I or IGF-II, IGFBPs, insulin, glucagon, somatostatin, BrdU, PCNA, cyclin D1, NEK2 or iNOS; or demonstrating apoptotic nuclei, was calculated at each age from up to five sections of each pancreas representing predominantly the head regions. This was because we have previously shown that the impact of LP diet on islet size is greater in the head than in the tail of the pancreas (5). Sections chosen contained at least five islets, and pancreata from up to 10 animals were examined for each age. Individual cell area, and total areas of immunoreactive cells within islets were circled for image analysis and selected by gray-level threshhold. Pancreatic ␤ cell mass was calculated following immunohistochemistry for insulin on sections obtained throughout pancreata of known weight. The mean ␤ cell volume was found to be 650 m 3 . ␤ cell mass was estimated by calculating the mean percentage area of tissue containing cells immunoreactive for insulin per sectional area of pancreas (five to six sections per organ). This was then expressed as mg ␤ cell mass based on the total pancreatic wet weight for individual animals. For Northern blot analysis the ratio of hybridization signal for IGF-II compared with 18S rRNA was calculated at each age for each of three separate pancreata following scanning densitometry. Differences between mean values for variables within individual experiments were compared statistically by two way ANOVA, followed by a Scheffé's test.
Results
Metabolism
Feeding of LP diet significantly reduced mean fetal body weight at 19.5 or 21.5 days gestation, compared with animals fed control diet (day 19.5, control 2.03 Ϯ 0.03 g, LP 1.89 Ϯ 0.05 g, P Ͻ 0.02; day 21.5, control 4.48 Ϯ 0.06 g, LP 4.14 Ϯ 0.14 g, P Ͻ 0.05; mean Ϯ sem, n ϭ 15-20). Pups born to mothers receiving LP diet continued to have a lower body weight postnatally, and grew at a reduced velocity until postnatal day 21 when they had a mean body weight 33% less than controls (control 42.02 Ϯ 2.31 g, LP 27.80 Ϯ 1.71 g, P Ͻ 0.001, n ϭ 5 per group). The mean pancreatic weight did not significantly differ between control and LP groups in the fetus and newborn but was significantly less in the LP group by postnatal day 2. At postnatal day 14 the weight of the pancreas was 46% less in offspring of LP-fed rats compared with controls (Fig. 1A) . Blood glucose levels in fetuses of both LP and control fed rats did not differ significantly at any age. At gestational age 19.5 days the mean (Ϯsem) blood glucose value was 46.5 Ϯ 3.5 mg/dl, on the day of birth 96.8 Ϯ 4.4 mg/dl, and on postnatal day 10, 123.6 Ϯ 2.9 mg/dl (n ϭ 10 per group). Thereafter, no substantial change was seen up to 21 days of age. Mean plasma insulin levels did not significantly differ between offspring of LP and control rats. The combined mean insulin values decreased sharply after birth in both diet groups, being 8.4 Ϯ 0.7 ng/ml on day 21.5 gestation, 4.6 Ϯ 0.6 ng/ml on postnatal day 2, and 1.8 Ϯ 0.7 ng/ml by postnatal day 21 (n ϭ 10 per group). At postnatal day 21 the pancreatic insulin content of LP rats was significantly less than in control animals (control 18 
Morphology
The mean area of islets was compared between LP and control fed rats at 19.5 days gestation, and postnatal days 14 and 21. Mean islet area increased from approximately 10,000 m 2 in late fetal life to 25,000 m 2 by postnatal day 21 in the control group (Fig. 1B) . The mean islet area was significantly reduced by more than 50% at each age in the LP group. The mean ␤ cell mass per pancreas was calculated and found to be reduced by greater than 50% in LP compared with control rats at fetal and neonatal ages, and by 70% at postnatal day 14 ( Table 1) . Analysis of the abundance of endocrine cell types within the islets showed that the relative distributions did not alter with age, but that ␤ cells containing immunoreactive insulin made up a significantly smaller area of the islets from LP rats at all ages, whereas ␣ cells containing immunoreactive glucagon constituted a larger area (P Ͻ 0.001) ( Table 2 ). Consequently, the insulin/glucagon ratio for relative immunoreactive islet area was decreased at all ages in LP animals (P Ͻ 0.001). The area occupied by somatostatincontaining D cells was not significantly altered between LP and control rat islets at most ages (Table 2 ). Individual endocrine cells did not differ in size between control and LP animals, suggesting that the above results reflected differences in relative cell number. When apoptosing cells within islets were also considered (Fig. 3D) , which did not show immunoreactivity for any pancreatic endocrine hormone, over 93% of islet cells could be accounted for, the balance probably reflecting pancreatic polypeptide-containing cells that were not analyzed. Thus, the islets in LP rats were smaller and contained a relatively smaller proportion of ␤ cells compared with controls throughout fetal and neonatal life.
Cell cycle analysis
Cells traversing S phase of the replication cycle were labeled in vivo with BrdU before rats were killed, which was then visualized within histological sections of pancreas using immunocytochemistry (Fig. 2, A and B) . The overall labeling index of islet cells with BrdU was 4 -5% in control fed animals, and did not alter with age. The percent islet cells labeled with BrdU in LP rats was significantly lower (control 4.4 Ϯ 0.1%, LP 2.6 Ϯ 0.1%, n ϭ 15 representing five animals each at gestational day 21.5 and postnatal days 14 and 21, P Ͻ 0.001). Dual staining for insulin and BrdU showed that most cells, which labeled with BrdU were ␤ cells, that this proportion did not change with age, but that a significantly lower percentage of cells that were BrdU-positive in LP animals were identified as ␤ cells (control 78.0 Ϯ 2.3%, LP 62.1 Ϯ 3.5%, P Ͻ 0.001, n ϭ 50 animals for control and 101 for LP). This suggests that the labeling of ␤ cells with BrdU was in proportion to their relative abundance in the islets of both control and LP animals.
As an additional parameter of islet cell replication, sections of pancreas were examined for the presence of PCNA by immunohistochemistry. PCNA is present in cell nuclei within the later part of G1, S, and G2 phases of the cell cycle. In animals fed control diet, the islet cell labeling index for PCNA was between 1% and 4%, with a transient increase at postnatal day 12. In contrast to findings with BrdU labeling, the percentage of islet cells immunopositive for PCNA was significantly greater in LP compared with control rats at every age up to postnatal day 17 (Fig. 3A) . When only ␤ cells were considered, the percentage of ␤ cells that demonstrated immunoreactivity for PCNA and insulin was also significantly greater in islets of LP animals and did not significantly differ with age (control 2.3 Ϯ 0.8%, LP 3.6 Ϯ 0.9%, P Ͻ 0.001, n ϭ 63 for control and 60 for LP). Approximately 60 -70% of cells containing PCNA immunoreactivity were ␤ cells, and this did not significantly alter with age or with diet (not shown).
To further delineate cell cycle events in islet cells in situ, immunohistochemistry was performed for cyclin D1 and for NEK2. Cyclin D1 is associated with G1 phase of the cell cycle, whereas NEK2 has a cell cycle-dependent expression that is maximal in G2 and M. Cyclin D1 was visualized in the cytoplasm of a minority of islet cells, and in some acinar epithelial cells (Fig. 2, C and D) . The percentage of ␤ cells that demonstrated immunoreactivity for cyclin D1 did not change with age in control-fed animals, but was significantly greater in LP-fed animals than in the control animals in late fetal life and at postnatal days 14 and 17 (Fig. 3B) . NEK2 immunoreactivity was seen in the nuclei of a minority of islet cells and in clusters of acinar cells at all ages (Fig. 2, E and  F) . In rats given LP diet the percentage of ␤ cells demonstrating NEK2 immunoreactivity was significantly reduced between postnatal days 10 and 17 (Fig. 3C) . Thus, indicators of S phase transition and G2/M of the cell cycle for ␤ cells (BrdU and NEK2) showed a decreased incidence in LP rats postnatally, while indicators of G1 phase (PCNA and cyclin D1) demonstrated an increased incidence.
Apoptosis
The occurrence of apoptosis within islet cells at each age was examined by molecular histochemistry using the TUNEL method. Apoptosing cells were restricted to the central, ␤-cell rich region of the islets (Fig. 2, G and H) . In the pancreas of control animals the proportion of islet cells undergoing apoptosis was less than 2%, before postnatal day 10, but a transient rise in islet cell apoptosis occurred between days 12 and 17, which was maximal at 8% on postnatal day 14 (Fig. 3D) . In offspring of rats receiving the LP diet, the incidence of islet cell apoptosis was significantly higher at every age examined, including the transient neonatal rise on days 12-17. Colocalization immunohistochemistry failed to demonstrate the presence of immunoreactive insulin or glu- cagon in apoptosing cells, which may be due to the withdrawal of cytoplasm around the apoptotic nuclei. Because we previously showed that there was a transient increase in the number of ␤ cells containing iNOS immediately before the neonatal rise in ␤ cell apoptosis (14), we compared the number of islet cells immunopositive for iNOS between controlfed and LP rats. Approximately 1% of islet cells were immunoreactive for iNOS in late fetal life, rising to a transient peak of 14% on postnatal day 12, which subsequently declined to 5% on postnatal day 21. No significant difference was found between control and LP fed rats.
IGF axis
To determine if the altered proliferation and survival of islet cells seen in rats fed LP diet were associated with alterations to the IGF axis in pancreas, the abundance of mRNA for IGF-II was determined in whole pancreata using Northern blot hybridization. Three mRNA transcripts for IGF-II were detected of 7.5 kb, 4.4 kb, and 2.4 kb in pancreata of both control and LP fed rats. In control fed animals the expression of all IGF-II mRNA transcripts declined postnatally and was barely detectable after postnatal day 14 (Fig. 4) . In LP fed rats, the expression IGF-II was reduced compared with controls at all ages. IGF-II mRNA expression was expressed relative to that of 18S ribosomal RNA in the same samples for three additional, separate hybridizations using pancreata from different animals and is shown in Fig. 5, A and B , for the two larger mRNA transcripts. This confirmed that the expression of IGF-II mRNA was reduced in the pancreata of LP fed rats, this being most pronounced for the 7.4 kb transcript. To determine whether the sites of expression of IGF-II in pancreas were altered in the neonatal LP fed animals, mRNA was visualized by in situ hybridization. IGF-II mRNA was located predominently in islet cells, and at postnatal day 2 was less abundant in pancreas sections from LP compared with control-fed rats (Fig. 6, A and B) . IGF-I mRNA was barely detectable using in situ hybridization in the islets of fetal or neonatal rats. By postnatal day 21 IGF-I mRNA was located within acinar cells, but did not obviously differ between dietary groups (not shown).
IGF-II immunoreactivity was visualized within pancreata by immunohistochemistry. IGF-II was abundant in islet cells in the fetus (Fig. 6, D and E) , but declined in intensity and in the number of immunopositive cells postnatally, to become barely detectable by postnatal day 21 (Fig. 5C ). Rats fed LP diet showed a significantly reduced area of islets containing immunoreactive IGF-II compared with control-fed animals. Immunoreactivity for IGF-I was low in the fetal pancreas (day 21.5 gestation, control 8.6 Ϯ 0.4% islet cell area, n ϭ 12) but appeared postnatally in association with islet cells and some acinar epithelial cells (day 21, 13.7 Ϯ 0.2% islet cell area, n ϭ 20). The area of islets immunopositive for IGF-I did not significantly differ between control and LP animals at any age. The presence of IGFBPs in the pancreas was also investigated using immunohistochemistry. Immunoreactive IGFBP-1 was diffusely present in islet cells in the fetus, and abundance declined with age (not shown). IGFBP-2 immunoreactivity was predominantly associated with the outer mantle of islet cells, comprising mostly ␣ cells, and vascular endothelium and did not change greatly with age. Immunoreactivity for IGFBP-3 and -4 was seen at all ages within the pancreas, within islets and mesenchymal tissue, but not in most acinar cells, whereas IGFBP-5 was seen at all ages associated with the ␣ cells of the islets and with ductal epithelial cells. No differences were found between the area of islets immunopositive for any IGFBP at any age between control-fed and LP-fed rats.
Discussion
The experimental induction of IUGR in the rat by a variety of methods results in alterations in the endocrine pancreas (5), reduced pancreatic weight and ␤ cell mass at birth (36 -38) , and lower insulin secretion in later life (6, 8) . This study shows that LP diet given during fetal and early postnatal life induced not only growth retardation, but disturbed the balance between ␤ cell proliferation and ␤ cell death. Amino acids are more potent in the stimulation of fetal islet cell proliferation than is glucose, are more potent insulin secretogogues (39) , and their profiles are altered in the maternal circulation following the administration of LP diet (4). A reduction in pancreatic weight was not apparent until after birth in LP animals, although the mean islet area was significantly reduced from at least 19.5 days gestation. The primary impact of protein restriction is on the proliferation of existing ␤ cells, which differs from observations in pups from maternal caloric restriction where neogenesis is affected, whereas proliferation rate was normal (36). We have not measured islet cell neogenesis in the LP diet model, but one cannot exclude a contribution to the reduced islet cell mass since when a normal diet is replaced immediately following birth, the islets in adult life are larger than in controls, whereas the total volume density of endocrine tissue is decreased (7, 8) . This suggests that the number of islets may be reduced. In the present study ␤ cell mass per pancreas was substantially reduced by LP diet, due to islets of smaller mean volume. This was due to a relative deficiency of ␣, ␤, and somatostatin-secreting cells, although the ␤ cell population was most severely effected. If nutritional restriction is reversed at birth or maintained until adulthood the islet morphology remains unaltered (8) . In both situations lower insulin secretion is apparent in adult life, although this is more severe if LP diet is continued to adulthood. This sug- gests that LP diet causes a fundamental reprogramming of ␤ cell phenotype with critical periods both in fetal and neonatal life. Our results suggest some possible mechanisms as to how this may occur. We showed previously that feeding an LP diet throughout gestation resulted in a lower nuclear labeling index with [ 3 H] thymidine in islet cells of the newborn (5), findings reproduced here with BrdU. Labeling with BrdU in ␤ cells within islets from control-fed animals was consistent with the fractional contribution of ␤ cells to these islets, demonstrating an equivalent labeling index for ␤ and non␤ cell types. In animals fed LP diet significantly less labeling with BrdU was located in ␤ cells, consistent with their reduced fractional area, and suggesting that the reduction in islet size is preferentially linked to a deficit in ␤ cell proliferation. The fraction of cells containing immunoreactivity for PCNA, either in all islet cells or specifically in the ␤ cell population was, paradoxically, increased at every age up to postnatal day 17 in LP animals. PCNA is an auxiliary protein of DNA polymerase that begins to accumulate in the nucleus during G1 of the cell cycle, is most abundant in S phase and declines during G2/M (40) . The observation that more ␤ cells contained detectable PCNA following LP diet, despite less cells being observed in S phase by incorporation of BrdU, could be explained by an altered cell cycle kinetics in which either G1 or G2/M phases were extended in LP animals. Alternatively, because PCNA is also expressed during DNA repair (41) , it is possible that islets from LP-fed rats were subject to oxidative, or some other physiological stress. To distinguish between these alternatives we further examined immunore- activity for cyclin D1 and for NEK2. Cyclin D1 is a nuclear protein that accumulates in G1 and is necessary for transition from G1 to S phase of the cell cycle (42) . It associates with PCNA and cyclin-dependent kinase 2 (43) . NEK2 is a serine/ threonine kinase that accumulates at the G2 to M phase transition and is necessary for progression into cell mitosis (44) . The fractional increase of ␤ cells in LP rats containing immunoreactive cyclin D1, and a decrease of NEK2 staining would be consistent with a lengthened mean cell cycle duration in ␤ cells within islets from LP rats, in which the G1 phase of the cycle was extended. However, direct confirmation of this would require precise cell cycle kinetic analysis using isolated ␤ cells from these animals.
A modulation of mean islet area by diet might involve a change in the rate of cell attrition as well as altered proliferative rate. A low rate of islet cell apoptosis exists in the fetal rat islet, but this transiently increases at 14 to 17 days postnatal life, to return to minimal levels by weaning (12, 14) . The rate of islet cell apoptosis was increased at every age examined in LP rats between late fetal life and weaning, compared with control-fed animals. However, the timing of the neonatal wave of apoptosis was not altered, suggesting that this event is qualitatively independent of diet of the mother. It is not possible to directly show that the apoptozing islet cells are ␤ cells because they no longer contain immunoreactive insulin. As we have described previously (14) , this may be due to a loss of cytoplasm rendering any immunohistochemical signal difficult to visualize. However, their predominantly central location within the islets is consistent with the majority having been ␤ cells. In addition, we have previously demonstrated that the majority of apoptotic islet cells express the glucose transporter protein GLUT2 on the plasma membrane, suggesting that they are derived from ␤ cells (45) . The percent of islet cells undergoing apoptosis in late fetal and early neonatal life is lower than we reported in a previous study of ontogeny, although the ontological pattern is identical (14) . This may be due to the use of a separate, inbred rat colony in the present study. We have shown previously that the neonatal wave of islet cell apoptosis is preceded by a transient increase in the presence of iNOS within ␤ cells (14) , which may be functionally linked to the developmental apoptosis. While a similar rise in islet cell iNOS immunoreactivity was seen in the LP animals, the percentage of immunopositive islet cells did not differ between control and LP diets. This suggests that the mechanisms underlying an increased rate of islet cell apoptosis seen in LP animals are unlikely to be due to increased detectable iNOS.
The transient increase in islet cell apoptosis in the neonatal rat is temporally related to a rapid loss of expression of IGF-II mRNA from the pancreas, where it is predominantly expressed within islet cells (14, 17) , and we have shown that endogenous IGF-II acts as a survival factor that prevents apoptosis in isolated islets from 5-day old rats (14) . While an increasing expression of IGF-I mRNA occurs in the pancreas postnatally, this is located mainly in the acinar tissue, not in the islets of Langerhans (14) . In the pancreata from LP rats, a reduced expression of IGF-II mRNA was found at fetal and neonatal ages, before the developmentally associated decline in IGF-II expression that occurs from day 14. It is not known if these changes reflect an effect of diet on gene transcription or on the stability of the mRNAs. For animals receiving both control and LP diet, the major sites of IGF-II expression in the pancreas, assessed by in situ hybridization, were the islets. The number of islet cells that were immunoreactive for IGF-II was also significantly reduced in LP animals, confirming that differences are also likely to be present at the level of the translated protein. These findings are consistent with an action of endogenous IGF-II as a survival factor for pancreatic ␤ cells, and suggest that the increased apoptosis seen in islet cells in LP rats may be functionally linked to a reduced expression of IGF-II. Because IGF-II will also increase islet cell DNA synthesis (19, 46) , its relative paucity in the islets of LP rats may also contribute directly to reduced ␤ cell proliferation rate and the reduction in islet size. It has been recently proposed that amino acids, and in particular branched-chain amino acids, may promote ␤ cell proliferation by stimulating phosphorylation of PHAS-1 (a regulator of translation initiation during mitogenesis) and by facilitating the proliferative effects mediated by growth factors (47) . Branched-chain amino acids are most severely depleted in the plasma of fetuses from LP-fed mothers (4), which could also contribute to the lower rate of ␤ cell proliferation in the pancreas of the LP pups. An effect of LP diet on pancreatic IGF-II expression may be direct. We showed previously that the release of immunoreactive IGF-II from isolated fetal rat islets was potentiated by amino acids, but not by glucose, whereas the release of insulin was increased by both (19) . Circulating levels of IGF-II in the rat fetus, which derive predominantly from an hepatic expression, are not substantially decreased during models of IUGR, although the much lower levels of circulating IGF-I are depressed (29, 30) . This would suggest that the development of the pancreatic islets is more sensitive to changes in locally expressed IGF-II than to circulatory changes, and that a paracrine or autocrine action of IGF-II is dominant in this tissue. No significant changes were seen in the fractional area of islets demonstrating immunoreactivity for IGF-I or IGFBPs in LP-fed animals. We have shown that increased concentrations of amino acids will increase IGFBP-1, -2, and -3 release from isolated fetal rat islets (19) , while the release of IGFBP-1 and -2 from islets is glucoseresponsive in the fetal rat or adult hamster (19, 32) . Mice expressing the human IGFBP-1 transgene have an increased pancreatic islet size with relatively more ␤ cells (48) . It is possible that any changes in IGFBP abundance within the islets of LP rats were too subtle to be detected by immunohistochemistry alone, and an influence of diet on IGFBP synthesis and secretion from islet cells is still possible.
In summary, the experiments suggest that LP diet causes a selective deficiency of ␤ cells in the fetus and neonate due to the combined effects of a reduced ␤ cell proliferation rate, which may involve an altered cell cycle length, and an increased incidence of apoptosis. These changes are associated with a decreased expression of IGF-II within the pancreatic islets, a growth factor known to act as a ␤ cell mitogen and to prevent apoptosis. It is therefore possible that perturbations of prenatal or neonatal nutrition and growth will lead to inappropriate ␤ cell ontogeny in the preweaning period, and result in a population of ␤ cells that may subsequently be functionally compromised in later life, contributing to glucose intolerance.
